Short-course adaptive radiotherapy for endometrial cancer after surgery
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial is testing a shorter course of radiation therapy that adapts to your body's changes each day, for women with endometrial cancer after surgery. It aims to see if this approach is well-tolerated and feasible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with endometrial cancer (including common types like endometrioid, serous, or clear cell).
- You are 18 years or older.
- Your cancer was completely removed during surgery.
- Your doctor recommends radiation therapy after surgery because your cancer has a higher risk of coming back.
- If you need chemotherapy, it must be finished at least 3 weeks before radiation starts.
- You are able to care for yourself (WHO performance status 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new type of radiation therapy (called online adaptive radiotherapy) given in shorter, higher daily doses after surgery for high-risk endometrial cancer. The goal is to see if this approach is safe and effective for reducing side effects while still controlling the cancer.
This study tests a shorter, more intense course of radiation therapy after surgery for endometrial cancer. It aims to see if it is safe and works as well as standard radiation, while possibly reducing treatment time.
This trial tests whether using tumor “molecular” results plus standard risk factors can guide the best type and timing of radiation after surgery for early-stage endometrial cancer. It may help you avoid under- or overtreatment by matching radiotherapy to your specific risk.
This trial tests a new way to deliver radiation therapy to endometrial cancer patients after surgery, using MRI scans to precisely target the treatment area. The goal is to improve accuracy while potentially reducing side effects.
This trial tests a shorter, more targeted type of radiation therapy for people with endometrial or cervical cancer who have had surgery. It aims to reduce side effects by using daily scans to adjust the treatment plan.
This trial tests a shorter, focused radiation treatment to the pelvis after surgery for cervical or uterine cancer. It aims to reduce the chance of cancer coming back in patients whose doctors recommend additional radiation therapy after their surgery.
Hear when a new Endometrial Carcinoma (EC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.